Literature DB >> 16818376

Amino-terminal processing of the human cannabinoid receptor 1.

Rickard Nordström1, Helena Andersson.   

Abstract

The human cannabinoid receptor 1 (CB1), a G protein-coupled receptor (GPCR), translocates its long amino-terminal (N-terminal) domain across the endoplasmic reticulum (ER) membrane in a C-to-N terminal direction. Using the Semliki Forest virus (SFV) expression system, CB1 was expressed in baby hamster kidney (BHK) cells. It was found that a large fraction of the CB1 molecules were N-terminally truncated prior to ER translocation. Truncation was fast and independent of the proteasome. It is concluded that the truncation process might be a way to create a novel type of CB1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818376     DOI: 10.1080/10799890600758252

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  8 in total

1.  Discovery and characterization of two novel CB1 receptor splice variants with modified N-termini in mouse.

Authors:  Sabine Ruehle; James Wager-Miller; Alex Straiker; Jill Farnsworth; Michelle N Murphy; Sebastian Loch; Krisztina Monory; Ken Mackie; Beat Lutz
Journal:  J Neurochem       Date:  2017-07-18       Impact factor: 5.372

2.  GPR37 surface expression enhancement via N-terminal truncation or protein-protein interactions.

Authors:  Jill H Dunham; Rebecca C Meyer; Erin L Garcia; Randy A Hall
Journal:  Biochemistry       Date:  2009-11-03       Impact factor: 3.162

Review 3.  Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R).

Authors:  Alexandra Fletcher-Jones; Keri L Hildick; Ashley J Evans; Yasuko Nakamura; Jeremy M Henley; Kevin A Wilkinson
Journal:  Front Mol Neurosci       Date:  2020-06-12       Impact factor: 5.639

4.  The C-terminal helix 9 motif in rat cannabinoid receptor type 1 regulates axonal trafficking and surface expression.

Authors:  Alexandra Fletcher-Jones; Keri L Hildick; Ashley J Evans; Yasuko Nakamura; Kevin A Wilkinson; Jeremy M Henley
Journal:  Elife       Date:  2019-04-30       Impact factor: 8.140

5.  N-glycosylation of α1D-adrenergic receptor N-terminal domain is required for correct trafficking, function, and biogenesis.

Authors:  Eric M Janezic; Sophia My-Linh Lauer; Robert George Williams; Michael Chungyoun; Kyung-Soon Lee; Edelmar Navaluna; Ho-Tak Lau; Shao-En Ong; Chris Hague
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

6.  Subsynaptic Distribution, Lipid Raft Targeting and G Protein-Dependent Signalling of the Type 1 Cannabinoid Receptor in Synaptosomes from the Mouse Hippocampus and Frontal Cortex.

Authors:  Miquel Saumell-Esnaola; Sergio Barrondo; Gontzal García Del Caño; María Aranzazu Goicolea; Joan Sallés; Beat Lutz; Krisztina Monory
Journal:  Molecules       Date:  2021-11-16       Impact factor: 4.411

7.  Optimization of the Heterologous Expression of the Cannabinoid Type-1 (CB1) Receptor.

Authors:  Viktória B Horváth; Eszter Soltész-Katona; Éva Wisniewski; Anikó Rajki; Eszter Halász; Balázs Enyedi; László Hunyady; András Dávid Tóth; Gergő Szanda
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-20       Impact factor: 5.555

8.  Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1.

Authors:  Leyre Echeazarra; Gontzal García Del Caño; Sergio Barrondo; Imanol González-Burguera; Miquel Saumell-Esnaola; Xabier Aretxabala; Maider López de Jesús; Leire Borrega-Román; Susana Mato; Catherine Ledent; Carlos Matute; María Aranzazu Goicolea; Joan Sallés
Journal:  Histochem Cell Biol       Date:  2021-08-27       Impact factor: 4.304

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.